PLA2G5 Antikörper (N-Term)
-
- Target Alle PLA2G5 Antikörper anzeigen
- PLA2G5 (phospholipase A2, Group V (PLA2G5))
-
Bindungsspezifität
- N-Term
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser PLA2G5 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Marke
- IHC-plus™
- Spezifität
- Human PLA2G5
- Aufreinigung
- Immunoaffinity purified
- Immunogen
-
Synthetic peptide from N-Terminus of human PLA2G5 (P39877, NP_000920). Percent identity by BLAST analysis: Human, Chimpanzee, Gorilla, Gibbon, Marmoset (100%), Mouse, Rat, Hamster, Bovine, Bat (85%), Rabbit (84%).
Type of Immunogen: Synthetic peptide - Isotyp
- IgG
- Top Product
- Discover our top product PLA2G5 Primärantikörper
-
anti-phospholipase A2, Group V (PLA2G5) antibody
PLA2G5 Reaktivität: Human WB, IHC (p), IP Wirt: Maus Monoclonal MCL-3G1 unconjugated
anti-phospholipase A2, Group V (PLA2G5) antibodyPLA2G5 Reaktivität: Maus IF Wirt: Kaninchen Polyclonal unconjugated
anti-phospholipase A2, Group V (PLA2G5) (C-Term) antibodyPLA2G5 Reaktivität: Human, Rind (Kuh) WB Wirt: Kaninchen Polyclonal unconjugated
anti-phospholipase A2, Group V (PLA2G5) (N-Term) antibodyPLA2G5 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-phospholipase A2, Group V (PLA2G5) (N-Term) antibodyPLA2G5 Reaktivität: Maus, Ratte, Human, Rind (Kuh), Hund, Pferd, Kaninchen WB Wirt: Kaninchen Polyclonal unconjugated
anti-phospholipase A2, Group V (PLA2G5) (Middle Region) antibodyPLA2G5 Reaktivität: Ratte, Human, Rind (Kuh), Hund, Pferd, Meerschweinchen WB Wirt: Kaninchen Polyclonal unconjugated
anti-phospholipase A2, Group V (PLA2G5) (AA 103-132), (C-Term) antibodyPLA2G5 Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
-
Approved: IHC, IHC-P (10 μg/mL), WB (0.2 - 1 μg/mL)
Usage: Western Blot: Suggested dilution at 1 μg/mL in 5 % skim milk / PBS buffer, and HRP conjugated anti-Rabbit IgG should be diluted in 1: 50,000 - 100,000 as second antibody. ELISA titer in peptide based assay: 1:312500. - Kommentare
-
Target Species of Antibody: Human
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Distilled water
- Konzentration
- Lot specific
- Buffer
- Lyophilized from PBS with 2 % sucrose
- Handhabung
- Avoid repeat freeze-thaw cycles.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
- Target
- PLA2G5 (phospholipase A2, Group V (PLA2G5))
- Andere Bezeichnung
- PLA2G5 (PLA2G5 Produkte)
- Synonyme
- PLA2 antikoerper, sPLA2 antikoerper, FRFB antikoerper, GV-PLA2 antikoerper, PLA2-10 antikoerper, hVPLA(2) antikoerper, phospholipase A2 group V antikoerper, phospholipase A2, group V antikoerper, PLA2G5 antikoerper, Pla2g5 antikoerper
- Hintergrund
-
Name/Gene ID: PLA2G5
Family: Phospholipase
Synonyms: PLA2G5, GV-PLA2, HVPLA(2), FRFB, Phospholipase A2, group V, PLA2-10, Group V phospholipase A2 - Gen-ID
- 5322
- NCBI Accession
- NP_000920
- Pathways
- Inositol Metabolic Process
-
